Cancer triples the risk of Guillain-Barre syndrome Scientists have found that cancer can increase the risk of developing the rare Guillain-Barre syndrome by three times. This pathology provokes paralysis.

Researchers at the University of Aarhus in Denmark have found that cancer patients are three times more likely to experience severe neural pathology, Guillain-Barre syndrome.. These are the results of a study involving 6 million patients. They showed that 2% of those who experienced this syndrome, recently found out about the presence of malignant neoplasms.. However, only 0.6% of healthy people experienced cancer in the same time period..

Guillain-Barre syndrome can cause paralysis of the arms, legs or face, and also provoke severe pain in the patient. In the most severe cases, it causes life-threatening problems, including breathing problems and blood clots.. Mortality in this syndrome is approximately 5%..

One in every 50,000 Russians develops Guillain-Barre syndrome each year, usually after an infection that causes an overactive immune system..

While the latest study was observational, the authors argue that cancer patients typically undergo surgery that increases the risk of infections.. Finally, Guillain-Barre syndrome is called an extremely rare side effect of the coronavirus vaccine produced by AstraZeneca..

https://www. medicalforum. en/.

Keywords:.